Jul 21, 2012 05:11 PM IST | Source:

Accumulate United Phosphorus; target Rs 172: Emkay

Emkay Global Financial Services is bullish on United Phosphorus and has recommended accumulate rating on the stock with a target of Rs 172 in its July 20, 2012 research report.

  • bselive
  • nselive
Todays L/H

Emkay Global Financial Services is bullish on United Phosphorous and has recommended accumulate rating on the stock with a target of Rs 172 in its July 20, 2012 research report.

"United Phosphorus consol revenues increased by 19% yoy to Rs 22.1bn (higher than est) primarily driven by higher than estimated revenues from India. Exchange gain contributed 11% to growth while pricing increased by 5% with the balance 4% being contributed by volumes. Organic growth remains muted. Indian revenues grew by 16% yoy (driven by both price and volumes) while North American revenues grew by 32% yoy (mainly on account of currency depreciation). Europe and RoW market grew by 12%-15%."

"Though gross margins improved by 300bps yoy to 38%, EBITDA margins at 17.5% was below est. Seasonally weak quarter in Brazil pulled margins down however management is confident of aligning margins in Brazil market in line with company’s margins by FY13- 14 through various synergies. UPL’s PAT of Rs 2.2bn, +31% yoy, is adjusted for 1) Rs MTM loss of Rs 280mn included in interest cost and 2) MTM gain of Rs 100mn included in other income. Due to losses in Brazilian subsidiary company reported negative minority interest of Rs 0.3bn and reported profit stood at Rs 2bn."

"Erratic weather patterns globally pose key risks for agrochem industry in the near term. US is facing its worst drought in 25 years while Europe has witnessed one of the wettest seasons ever. Indian monsoons have been deficient which has impacted sowing of crops. Synergy benefit in Brazil and RoW markets, aggressive products launch in domestic markets through tie ups with global players and inorganic growth opportunities are key driving factors for the company."

"UPL’s acquisition of SD Agchem is likely to strengthen its European presence & enhance its product offerings. Management maintained its guidance of 15% revenues growth while they expect Brazilian margins to improve gradually. We est revenue / EBITDA / PAT growth of 9%/10%/18% and maintain Accumulate with target price of Rs 172 mainly on account of compelling valuations," says Emkay Global Financial Services research report.

Bodies Corporate holding more than 50% in Indian cos

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on are their own, and not that of the website or its management. advises users to check with certified experts before taking any investment decisions.

To read the full report click on the attachment

Follow us on
Available On